Medistim ASA
OSE:MEDI

Watchlist Manager
Medistim ASA Logo
Medistim ASA
OSE:MEDI
Watchlist
Price: 150 NOK -3.85% Market Closed
Market Cap: 2.7B NOK
Have any thoughts about
Medistim ASA?
Write Note

Medistim ASA
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medistim ASA
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Medistim ASA
OSE:MEDI
Additional Paid In Capital
kr44.2m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%
Lifecare AS
OSE:LIFE
Additional Paid In Capital
kr76m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
O
Observe Medical ASA
OSE:OBSRV
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medistim ASA
Glance View

Market Cap
2.7B NOK
Industry
Health Care

Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The firm provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.

MEDI Intrinsic Value
158.47 NOK
Undervaluation 5%
Intrinsic Value
Price

See Also

What is Medistim ASA's Additional Paid In Capital?
Additional Paid In Capital
44.2m NOK

Based on the financial report for Sep 30, 2024, Medistim ASA's Additional Paid In Capital amounts to 44.2m NOK.

What is Medistim ASA's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
1%

Over the last year, the Additional Paid In Capital growth was 0%.

Back to Top